Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients - PubMed (original) (raw)

. 2008 Oct;27(10):1243-8.

doi: 10.1007/s10067-008-0893-1. Epub 2008 Apr 22.

Affiliations

• PMID: 18427872
• DOI: 10.1007/s10067-008-0893-1

Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients

Omer Ates et al. Clin Rheumatol. 2008 Oct.

Abstract

Tumor necrosis factor and interleukin 10 have been implicated in the pathogenesis of rheumatoid arthritis (RA). Certain single-nucleotide polymorphisms (SNPs) within the promoter region of the IL-10 and TNF genes have been associated with altered levels of circulating IL10 and TNF. We aimed to explore the association of IL-10 and TNF-alpha polymorphisms in Turkish RA patients. We analyzed the association of TNF-alpha (-308G/A, -238G/A, -376G/A) and IL10 (-1082G/A, -819C/T, -592C/A) polymorphisms in 98 Turkish patients with rheumatoid arthritis and 122 healthy subjects using ARMS-PCR. The correlation of these findings with RF positivity and erosive disease in RA patients was also sought. A significant association was found between having RA and -1082 G allele (p=0.008; OR=1.44, 95% CI 1.11-1.86). There was no association between RA and -819C/T polymorphism. Significant differences were observed in IL10 GCC and ACC haplotypes distribution between RA and control subjects (p=0.006; OR=1.46, 95% CI 1.13-1.89 and p=0.011; OR=1.43, 95% CI 1.09-1.88, respectively). No statistically significant association was found between TNF-alpha 308G/A, -238G/A, -376G/A polymorphisms and RA. No significant association was found between RF positivity and erosive disease and TNF-alpha, IL10 gene polymorphisms. In addition, when combined genotypes were analyzed, no significant difference was found between RA patients and healthy controls. Our findings suggest that IL-10 1082 G/A polymorphism or GCC, ACC haplotypes may be associated with RA in Turkish patients.

PubMed Disclaimer

Similar articles

• Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome.
  Ateş O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarıkaya A. Ateş O, et al. Mol Biol Rep. 2010 Oct;37(7):3637-41. doi: 10.1007/s11033-010-0015-4. Epub 2010 Feb 27. Mol Biol Rep. 2010. PMID: 20191386
• Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.
  Cadena-Sandoval D, Alemán-Ávila I, Barbosa-Cobos RE, Becerril-Mendoza LT, Fragoso JM, Ramírez-Bello J. Cadena-Sandoval D, et al. Mol Biol Rep. 2018 Jun;45(3):227-232. doi: 10.1007/s11033-018-4155-2. Epub 2018 Feb 5. Mol Biol Rep. 2018. PMID: 29404828
• Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
  Lagha A, Zidi S, Stayoussef M, Gazouani E, Kochkar R, Kochbati S, Almawi WY, Yacoubi-Loueslati B. Lagha A, et al. Pathol Biol (Paris). 2015 Sep;63(4-5):179-84. doi: 10.1016/j.patbio.2015.04.004. Epub 2015 May 21. Pathol Biol (Paris). 2015. PMID: 26003199
• Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk.
  Liang Y, Xu WD, Zhang M, Qiu LJ, Ni J, Wang XS, Wen PF, Cen H, Leng RX, Pan HF, Ye DQ. Liang Y, et al. Int J Rheum Dis. 2013 Dec;16(6):616-24. doi: 10.1111/1756-185X.12221. Epub 2013 Nov 25. Int J Rheum Dis. 2013. PMID: 24267724 Review.
• Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.
  Harrison P, Pointon JJ, Chapman K, Roddam A, Wordsworth BP. Harrison P, et al. Rheumatology (Oxford). 2008 Dec;47(12):1768-70. doi: 10.1093/rheumatology/ken374. Epub 2008 Oct 4. Rheumatology (Oxford). 2008. PMID: 18838388 Review.

Cited by

• Association between tumor necrosis factor polymorphisms and rheumatoid arthritis as well as systemic lupus erythematosus: a meta-analysis.
  Chen L, Huang Z, Liao Y, Yang B, Zhang J. Chen L, et al. Braz J Med Biol Res. 2019 Mar 25;52(3):e7927. doi: 10.1590/1414-431X20187927. Braz J Med Biol Res. 2019. PMID: 30916218 Free PMC article.
• Usefulness of Cytokine Gene Polymorphisms for the Therapeutic Choice in Japanese Patients with Rheumatoid Arthritis.
  Tsujimoto S, Ozaki Y, Ito T, Nomura S. Tsujimoto S, et al. Int J Gen Med. 2021 Jan 14;14:131-139. doi: 10.2147/IJGM.S287505. eCollection 2021. Int J Gen Med. 2021. PMID: 33469350 Free PMC article.
• Association of Interleukin-10 Genotypes and Anticyclic Citrullinated Peptide Antibodies with Rheumatoid Arthritis.
  Moghimi N, Afkhamzadeh A, Rahmani K, Shakiba N. Moghimi N, et al. Med J Islam Repub Iran. 2022 Aug 22;36:95. doi: 10.47176/mjiri.36.95. eCollection 2022. Med J Islam Repub Iran. 2022. PMID: 36408339 Free PMC article.
• Tumor Necrosis Factor Alpha Gene Polymorphism and Association With Its Serum Level in Iranian Population with Rheumatoid Arthritis.
  Hadinedoushan H, Noorbakhsh P, Soleymani-Salehabadi H. Hadinedoushan H, et al. Arch Rheumatol. 2016 Jul 27;31(4):306-313. doi: 10.5606/ArchRheumatol.2016.5907. eCollection 2016 Dec. Arch Rheumatol. 2016. PMID: 30375554 Free PMC article.
• Association between TNF-α promoter -308 A/G polymorphism and rheumatoid arthritis: a meta-analysis.
  Song GG, Bae SC, Kim JH, Lee YH. Song GG, et al. Rheumatol Int. 2014 Apr;34(4):465-71. doi: 10.1007/s00296-013-2919-5. Epub 2013 Dec 5. Rheumatol Int. 2014. PMID: 24306269 Review.

References

1. 1. Hum Immunol. 2001 Jul;62(7):705-13 - PubMed
2. 1. Lancet. 1997 Jan 18;349(9046):170-3 - PubMed
3. 1. Ann Rheum Dis. 2004 Mar;63(3):280-4 - PubMed
4. 1. J Rheumatol. 2001 Aug;28(8):1788-92 - PubMed
5. 1. Tissue Antigens. 1999 Aug;54(2):194-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information